We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,438 results
  1. Entry of cannabidiol into the fetal, postnatal and adult rat brain

    Cannabidiol is a major component of cannabis but without known psychoactive properties. A wide range of properties have been attributed to it, such...

    Georgia Fitzpatrick, Yifan Huang, ... Norman R. Saunders in Cell and Tissue Research
    Article Open access 17 February 2024
  2. Dual-step pharmacological intervention for traumatic-like memories: implications from D-cycloserine and cannabidiol or clonidine in male and female rats

    Rationale

    Therapeutic approaches to mitigating traumatic memories have often faced resistance. Exploring safe reconsolidation blockers, drugs capable...

    Luciane A. Soares, Laura M. M. Nascimento, ... Leandro J. Bertoglio in Psychopharmacology
    Article 01 May 2024
  3. Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment

    Multiple lines of evidence suggest a central role for the endocannabinoid system (ECS) in the neuronal development and cognitive function and in the...

    Joseph M. Palumbo, Brian F. Thomas, ... Terri Sebree in Journal of Neurodevelopmental Disorders
    Article Open access 09 January 2023
  4. Prospective affirmative therapeutics of cannabidiol oil mitigates doxorubicin-induced abnormalities in kidney function, inflammation, and renal tissue changes

    Nephropathy is the decline in kidney function. A promising treatment for numerous types of illness is using natural materials as natural chemical...

    Nabil A. Soliman, Samih I. El Dahmy, ... Khadija A. Mohammed in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 16 November 2023
  5. High Concentrations of Cannabidiol Induce Neurotoxicity in Neurosphere Culture System

    Recent studies have demonstrated that cannabinoids are potentially effective in the treatment of various neurological conditions, and cannabidiol...

    Simone A. A. Romariz, Viviam Sanabria, ... Beatriz M. Longo in Neurotoxicity Research
    Article 13 February 2024
  6. The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials

    Background

    Legislative changes have fueled the global availability of cannabis and cannabis-derived compounds, such as cannabidiol. Little is known...

    Yuni Tang, Kolbi L. Tonkovich, Toni Marie Rudisill in Pharmaceutical Medicine
    Article 21 October 2022
  7. Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products

    Background and Objectives

    A wide variety of products containing cannabidiol (CBD) are available on the commercial market. One of the most common...

    Erin C. Berthold, Shyam H. Kamble, ... Abhisheak Sharma in European Journal of Drug Metabolism and Pharmacokinetics
    Article 19 June 2023
  8. Quantitative summary on the human pharmacokinetic properties of cannabidiol to accelerate scientific clinical application of cannabis

    Cannabidiol (CBD) is a non-psychoactive substance that exerts numerous pharmacological benefits, including anti-inflammatory and antioxidant...

    Ji-Hun Jang, Ju-Hwan Jeong, Seung-Hyun Jeong in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 June 2024
  9. Effectiveness of cannabidiol (CBD) on histopathological changes and gene expression in hepatocellular carcinoma (HCC) model in male rats: the role of Hedgehog (Hh) signaling pathway

    The third most prevalent malignancy to cause mortality is hepatocellular carcinoma (HCC). The Hedgehog (Hh) signaling pathway is activated by binding...

    Samia Hussein, Nabil A. Soliman, ... Fatma M. Mostafa in Histochemistry and Cell Biology
    Article 01 February 2024
  10. Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

    Cannabidiol (CBD) has become a highly attractive entity in therapeutics. However, its low aqueous solubility, instability and handling problems limit...

    Ana Isabel Fraguas-Sánchez, Dolores Hernán, ... Ana Isabel Torres-Suárez in Drug Delivery and Translational Research
    Article 12 October 2023
  11. Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor

    Cannabis sativa has been used for improving sleep for long history. Cannabidiol (CBD) has drown much attention as a non-addictive psychoactive...

    Yu-Meng Liu, **-Cao Li, ... You-Zhi Zhang in Neurochemical Research
    Article 31 January 2024
  12. Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery

    Cannabidiol (CBD) has been recognized for its numerous therapeutic benefits, such as neuroprotection, anti-inflammatory effects, and...

    Sadikalmahdi Abdella, Sangseo Kim, ... Sanjay Garg in Drug Delivery and Translational Research
    Article Open access 30 October 2023
  13. Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction

    Rationale

    Preclinical research suggests that pharmacologically elevating cannabinoid levels may attenuate fear memory expression and enhance fear...

    C. M. B. Kwee, F. E. van der Flier, ... J. M. P. Baas in Psychopharmacology
    Article 04 December 2023
  14. A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

    Background

    Fragile X syndrome (FXS) is associated with dysregulated endocannabinoid signaling and may therefore respond to cannabidiol therapy.

    ...
    Elizabeth Berry-Kravis, Randi Hagerman, ... Stephen O’Quinn in Journal of Neurodevelopmental Disorders
    Article Open access 25 November 2022
  15. Formulation Development and Evaluation of Cannabidiol Hot-Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications

    Cannabidiol (CBD) is a highly lipophilic compound with poor oral bioavailability, due to poor aqueous solubility and extensive pre-systemic...

    Kavish Sanil, Ahmed Almotairy, ... Eman A. Ashour in AAPS PharmSciTech
    Article 11 June 2024
  16. Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

    Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress,...

    Jeremy D. Henson, Luis Vitetta, Sean Hall in Inflammopharmacology
    Article Open access 07 July 2022
  17. Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors

    Cerebral metabolic abnormalities are common in neurodegenerative diseases. Previous studies have shown that mitochondrial damage alters ATP...

    Hind Ibork, Sara El Idrissi, ... Oualid Abboussi in Neurotoxicity Research
    Article 02 October 2023
  18. Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol

    KLS-13019 was reported previously to reverse paclitaxel-induced mechanical allodynia in a mouse model of chemotherapy-induced peripheral neuropathy...

    Douglas E. Brenneman, William A. Kinney, ... Sara Jane Ward in Journal of Molecular Neuroscience
    Article 11 April 2024
  19. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

    Rationale

    Autism spectrum disorder (ASD) is defined as a group of neurodevelopmental disorders whose symptoms include impaired communication and...

    João F. C. Pedrazzi, Frederico R. Ferreira, ... José A. S. Crippa in Psychopharmacology
    Article 29 July 2022
  20. Autophagic Molecular Alterations in the Mouse Cerebellum Experimental Autoimmune Encephalomyelitis Model Following Treatment with Cannabidiol and Fluoxetine

    The crosstalk between autophagy and apoptosis is one of the most important processes involved in the cell program death, and several mechanisms...

    Maryam Akhavan Tavakoli, Maryam Soleimani, ... Mehdi Mehdizadeh in Molecular Neurobiology
    Article 28 December 2022
Did you find what you were looking for? Share feedback.